Team publications

1. Bessoles S, Chiron A, Sarrabayrouse G, De La Grange P, Abina AM, Hacein-Bey-Abina S. Erythropoietin induces tumour progression and CD39 expression on immune cells in a preclinical model of triple-negative breast cancer. Immunology. 2024 Jul 2. doi: 10.1111/imm.13832. Online ahead of print.PMID: 38953295
2. Pinyon JL, von Jonquieres G, Crawford EN, Abed AA, Power JM, Klugmann M, Browne CJ, Housley DM, Wise AK, Fallon JB, Shepherd RK, Lin JY, McMahon C, McAlpine D, Birman CS, Lai W, Enke YL, Carter PM, Patrick JF, Gay RD, Marie C, Scherman D, Lovell NH, Housley GD. Gene Electrotransfer via Conductivity-Clamped Electric Field Focusing Pivots Sensori-Motor DNA Therapeutics: “A Spoonful of Sugar Helps the Medicine Go Down”. Adv Sci (Weinh). 2024 Aug;11(30):e2401392. doi: 10.1002/advs.202401392. Epub 2024 Jun 14.PMID: 38874431 Free PMC article.
3. Jiang Y, Lu H, Lei L, Yuan X, Scherman D, Liu Y. MOF-derived cobalt-iron containing nanocomposite with cascade-catalytic activities for multimodal synergistic tumor therapy. Colloids Surf B Biointerfaces. 2024 Aug;240:113981. doi: 10.1016/j.colsurfb.2024.113981. Epub 2024 May 20.PMID: 38815310
4. Marie C, Scherman D. Antibiotic-Free Gene Vectors: A 25-Year Journey to Clinical Trials. Genes (Basel). 2024 Feb 20;15(3):261. doi: 10.3390/genes15030261. PMID: 38540320 Free PMC article. Review.
5. Liu J, Viana B, Mignet N, Scherman D, Liu Y, Richard C. H2 O2 -Induced Persistent Luminescence Signal Enhancement Applied to Biosensing. Small. 2023 Dec;19(49):e2303509. doi: 10.1002/smll.202303509. Epub 2023 Aug 27. PMID: 37635118
6. Mignet N, Scherman D. Biodistribution via Europium Complexes.Methods Mol Biol. 2023;2622:277-287. doi: 10.1007/978-1-0716-2954-3_25.PMID: 36781770
7. Liao X, Nie J, Yuan X, Feng Z, Cui E, Wu Y, Li Y, Scherman D, Liu Y.Acta. Carbopol dispersed PAA-modified UIO-66 with high colloidal stability as a combination nano-adjuvant boosts immune response and protection against pseudorabies virus in mice and pigs. Biomater. 2023 Sep 15;168:540-550. doi: 10.1016/j.actbio.2023.06.039. Epub 2023 Jun 30.PMID: 37393970
8. Herrera-deGuise C, Varela E, Sarrabayrouse G, Pozuelo Del Río M, Alonso VR, Sainz NB, Casellas F, Mayorga LF, Manichanh C, Vidaur FA, Guarner F. Gut Microbiota Composition in Long-Remission Ulcerative Colitis is Close to a Healthy Gut Microbiota. Inflamm Bowel Dis. 2023 Sep 1;29(9):1362-1369. doi: 10.1093/ibd/izad058. PMID: 37655859
9. Campiol Arruda D, Lachagès AM, Demory H, Escriou G, Lai-Kuen R, Dugas PY, Hoffmann C, Bessoles S, Sarrabayrouse G, Malachias A, Finet S, Lana Gastelois P, de Almeida Macedo W, da Silva Cunha Jr A, Bigey P, Escriou V. Spheroplexes: Hybrid PLGA-cationic lipid nanoparticles, for in vitro and oral delivery of siRNA. J Control Release. 2022 Oct; 350:228-243. https://doi.org/1016/j.jconrel.2022.08.030.
10. Lécuyer T, Seguin J, Balfourier A, Delagrange M, Burckel P, Lai-Kuen R, Mignon V, Ducos B, Tharaud M, Saubaméa B, Scherman D, Mignet N, Gazeau F, Richard C. Fate and biological impact of persistent luminescence nanoparticles after injection in mice: a one-year follow-up. Nanoscale. 2022 Nov 3;14(42):15760-15771. https://doi.org/1039/d2nr03546d.
11. Lécuyer T, Bia N, Burckel P, Loubat C, Graillot A, Seguin J, Corvis Y, Liu J, Valéro L, Scherman D, Mignet N, Richard C. Persistent luminescence nanoparticles functionalized by polymers bearing phosphonic acid anchors: synthesis, characterization, and in vivo behaviour. Nanoscale. 2022 Jan 12. https://doi.org/1039/d1nr07114a.
12. Jiang Y, Lu H, Yuan X, Zhang Y, Lei L, Li Y, Sun W, Liu J, Scherman D, Liu Y. A hollow Co3-xCuxS4 with glutathione depleting and photothermal properties for synergistic dual-enhanced chemodynamic/photothermal cancer therapy. J Mater Chem B. 2022 Oct 12;10(39):8082-8093. https://doi.org/1039/d2tb01590k.
13. Kropp M, Harmening N, Bascuas T, Johnen S, De Clerck E, Fernández V, Ronchetti M, Cadossi R, Zanini C, Scherman D, Ivics Z, Marie C, Izsvák Z, Thumann G. GMP-Grade Manufacturing and Quality Control of a Non-Virally Engineered Advanced Therapy Medicinal Product for Personalized Treatment of Age-Related Macular Degeneration. Biomedicines. 2022 Nov 1;10(11):2777. https://doi.org/3390/biomedicines10112777.
14. Do HD, Marie C, Bessoles S, Dhotel H, Seguin J, Larrat B, Doan BT, Scherman D, Escriou V, Hacein-Bey-Abina S, Mignet N. Combination of thermal ablation by focused ultrasound, pFAR4-IL-12 transfection and lipidic adjuvant provide a distal immune response. Explor Target Antitumor Ther. 2022 ;3(6) :398-413. https://doi.org/37349/etat.2022.00090.
15. Flet-Berliac L, Tchitchek N, Lépine A, Florea A, Maurey H, Chrétien P, Hacein-Bey-Abina S, Villega F, Cheuret E, Rogemond V, Picard G, Honnorat J, Deiva K. Long-term outcome of paediatric anti-N-methyl-D-aspartate receptor encephalitis. Dev Med Child Neurol. 2022 Oct 5. https://doi.org/1111/dmcn.15429.
16. Berger A, Gleizes A, Waeckel L, Roblin X, Krzysiek R, Hacein-Bey-Abina S, Soriano A, Paul S. Validation Study of a New Random-Access Chemiluminescence Immunoassay Analyzer i-TRACK10® to Monitor Infliximab and Adalimumab Serum trough Levels and Anti-Drug Antibodies Int J Mol Sci. 2022 Aug 24;23(17): 9561. https://doi.org/3390/ijms23179561.
17. Peillet C, Adams D, Attarian S, Bouhour F, Cauquil C, Cassereau J, Chanson JB, Cintas P, Creange A, Delmont E, Fargeot G, Genestet S, Gueguen A, Kaminsky AL, Kuntzer T, Labeyrie C, Michaud M, Pereon Y, Puma A, Viala K, Chretien P, Adam C, Echaniz-Laguna A. Anti-disialosyl-immunoglobulin M chronic autoimmune neuropathies: a nationwide multicenter retrospective study. Eur J Neurol. 2022 Dec;29(12):3547-3555. https://doi.org/1111/ene.15523.
18. Magnani A, Semeraro M, F Adam, C Booth , L Dupré, E C Morris, A Gabrion, C Roudaut, D Borgel, A Toubert , E Clave, C Abdo, G Gorochov, R Petermann, M Guiot, M Miyara, D Moshous, E Magrin, A Denis, F Suarez, C Lagresle, A M Roche, J Everett, A Trinquand, M Guisset, J Xu Bayford, S Hacein-Bey-Abina, A Kauskot, R Elfeky, C Rivat, S Abbas, H B Gaspar, E Macintyre, C Picard, F D Bushman, A Galy, A Fischer, E Six, A J Thrasher, M Cavazzana. Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome. Nat Med 2022 Oct ;28(10): 2217. https://doi.org/1038/s41591-022-01985-y
19. Magnani A, Semeraro M, Adam F, Booth C, Dupré L, Morris EC, Gabrion A, Roudaut C, Borgel D, Toubert A, Clave E, Abdo C, Gorochov G, Petermann R, Guiot M, Miyara M, Moshous D, Magrin E, Denis A, Suarez F, Lagresle C, Roche AM, Everett J, Trinquand A, Guisset M, Bayford JX, Hacein-Bey-Abina S, Kauskot A, Elfeky R, Rivat C, Abbas S, Gaspar HB, Macintyre E, Picard C, Bushman FD, Galy A, Fischer A, Six E, Thrasher AJ, Cavazzana M. Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome. Nat Med. 2022 Jan;28(1):71-80. https://doi.org/1038/s41591-021-01641-x.
20. Magrin E, Semeraro M, Hebert N, Joseph L, Magnani A, Chalumeau A, Gabrion A, Roudaut C, Marouene J, Lefrere F, Diana JS, Denis A, Neven B, Funck-Brentano I, Negre O, Renolleau S, Brousse V, Kiger L, Touzot F, Poirot C, Bourget P, El Nemer W, Blanche S, Tréluyer JM, Asmal M, Walls C, Beuzard Y, Schmidt M, Hacein-Bey-Abina S, Asnafi V, Guichard I, Poirée M, Monpoux F, Touraine P, Brouzes C, de Montalembert M, Payen E, Six E, Ribeil JA, Miccio A, Bartolucci P, Leboulch P, Cavazzana M. Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trial. Nat Med. 2022 Jan;28(1):81-88. https://doi.org/1038/s41591-021-01650-w.
21. Andrea AE, Chiron A, Mallah S, Bessoles S, Sarrabayrouse G, Hacein-Bey-Abina S.Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment. Front Immunol. 2022 Feb 8;13:830292. doi: 10.3389/fimmu.2022.830292. eCollection 2022. PMID: 35211124 Free PMC article. Review.

© Lorem ipsum dolor sit amet, consectetuer adipiscing